CD4 Cell Count at Antiretroviral Therapy Initiation or Re- Initiation (CAIR)
The primary purpose of this study is to assess the burden of advanced HIV disease (CD4 cell count <200 or <350 cells/μL) among new patients and those returning to care after a gap in treatment, and the extent to which low coverage of CD4 cell count measurement among these patients may prevent adequate management of those with advanced HIV disease.
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy